Option chain shows key data for MiNK Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for MiNK Therapeutics.

MiNK Therapeutics (NASDAQ:INKT) Stock, Option Chain

MINK THERAPEUTICS INC

MiNK Therapeutics

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Stock_ chart_image_JPG

News

Movers

INKT

MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.

Why MiNK Therapeutics Stock Is Up 11% Monday

Penny Stocks

Small Cap

Intraday Update

Markets

Trading Ideas

ARDX

ATUS

BDSX

BROG

BYRN

Envoy Medical, Inc. - Class A Common Stock

COCH

DXYZ

FAAS

GCTS

GNLN

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HUBC

IMCC

JZXN

KRUS

Kintara Therapeutics, Inc. - Common Stock

KTRA

KZIA

LGVC

MDIA

NCNC

RELI

SBFM

SPCB

SPOT

STIX

Tempest Therapeutics, Inc. - Common Stock

TPST

XXII

NIVF

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Long Ideas

Insider Trades

Pre-Market Outlook

NTWK

SPGC

VANI

The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying

MiNK Therapeutics Inc

Health Care

Press Releases

MiNK's iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024

MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report

Earnings

MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting

MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI

Analyst Ratings

MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting

MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements

MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting

MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress

ALX Oncology Holdings Inc. - Common Stock

ALX Oncology Holdings

Annovis Bio

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

bluebird bio

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Clene

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Equillium

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroGen

Generation Bio

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

OSR Holdings

OS Therapies

Ovid Therapeutics

Passage Bio

Pluri

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Rallybio

Rein Therapeutics

RenovoRx

Surrozen

Tempest Therapeutics

HC Wainwright & Co.

Baird

Evercore ISI Group

Comments

MiNK Therapeutics

MiNK Therapeutics (INKT) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga